AWM Investment Company »

Rapt Therapeutics shares owned by AWM Investment Company

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.5M 163k 33.87

More positions owned by AWM Investment Company

nLight common (LASR)
ADMA Biologics common (ADMA)
Vicor Corporation common (VICR)
BlackSky Technology common (BKSY)
Aehr Test Systems common (AEHR)
Impinj common (PI)
Gilat Satellite Networks common (GILT)
Velo3D common (VELO)
Aerovironment common (AVAV)
Owlet common (OWLT)
Kopin Corporation common (KOPN)
908 Devices common (MASS)
PowerFleet common (AIOT)
Natural Gas Services Group, In common (NGS)
RealReal common (REAL)

View all positions for AWM Investment Company

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics